DRW8 Stock Chart & Stats
$67.59
$0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range$67.59 - $80.91
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
CHF1.71B
Enterprise Value$1.53K
Total Cash (Recent Filing)CHF198.46M
Total Debt (Recent Filing)CHF388.38M
Price to Earnings (P/E)12.1
Beta0.51
Next Earnings
Oct 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)9.14
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio0.74
Price to Book (P/B)0.80
Price to Sales (P/S)0.37
P/FCF Ratio7.81
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)8.37
Revenue Forecast (FY)CHF3.42B
Bulls Say, Bears Say
Bulls Say
Upgraded Margin GuidanceAn upgraded EBIT margin range and an explicit medium‑term margin ambition signal durable operational improvement priorities. If sustained, disciplined expense control and mix shifts can raise structural profitability, improving free cash flow generation and reinvestment capacity over the next several years.
Improving Cash Flow & Lower LeverageMaterially stronger operating and free cash flow, plus meaningful net debt reduction, enhance financial flexibility. This supports capex, R&D and working-capital needs, lowers refinancing risk, and provides a stable base for dividends or strategic investments over the medium term.
Safety Division Profitability & Recurring SalesThe Safety division’s strong top-line and margin expansion reflects durable product-market fit and likely recurring revenue from consumables, calibration and service. Higher divisional profitability reduces dependence on cyclical capital equipment cycles and stabilizes consolidated earnings.
Bears Say
Medical Division Profitability LagThe Medical segment remains a core revenue driver but showed negative EBIT in H1, indicating incomplete recovery. Persistent underperformance in this capital‑goods business can constrain group margin expansion, require continued investment or restructuring, and heighten earnings cyclicality.
Working Capital AbsorptionA sizable increase in net working capital ties up cash and can depress free cash flow despite profit improvements. If structural (inventory or receivables), higher NWC raises financing needs and makes cash conversion more volatile, limiting durable cash available for growth or debt paydown.
Rising Functional Costs & Freight HeadwindsSustained increases in personnel and freight costs compress margins unless offset by pricing or productivity gains. For a manufacturer with global supply chains, persistent cost inflation can erode margin progress and require ongoing price adjustments that risk competitiveness in tender-driven end markets.
DRW8 FAQ
What was Draegerwerk AG & Co. KGaA’s price range in the past 12 months?
Draegerwerk AG & Co. KGaA lowest stock price was $67.59 and its highest was $80.91 in the past 12 months.
What is Draegerwerk AG & Co. KGaA’s market cap?
Draegerwerk AG & Co. KGaA’s market cap is CHF1.71B.
When is Draegerwerk AG & Co. KGaA’s upcoming earnings report date?
Draegerwerk AG & Co. KGaA’s upcoming earnings report date is Oct 29, 2026 which is in 62 days.
How were Draegerwerk AG & Co. KGaA’s earnings last quarter?
Draegerwerk AG & Co. KGaA released its earnings results on Jul 30, 2026. The company reported $1.481 earnings per share for the quarter, the consensus estimate of $1.481 by $0.
Is Draegerwerk AG & Co. KGaA overvalued?
According to Wall Street analysts Draegerwerk AG & Co. KGaA’s price is currently Undervalued.
Does Draegerwerk AG & Co. KGaA pay dividends?
Draegerwerk AG & Co. KGaA does not currently pay dividends.
What is Draegerwerk AG & Co. KGaA’s EPS estimate?
Draegerwerk AG & Co. KGaA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Draegerwerk AG & Co. KGaA have?
Currently, no data Available
What happened to Draegerwerk AG & Co. KGaA’s price movement after its last earnings report?
Draegerwerk AG & Co. KGaA reported an EPS of $1.481 in its last earnings report, expectations of $1.481. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Draegerwerk AG & Co. KGaA?
Currently, no hedge funds are holding shares in CH:DRW8
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Draegerwerk AG & Co. KGaA Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
43.50%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
3.14%
Trailing 12-Months
Company Description
Draegerwerk AG & Co. KGaA
Headquartered in Lübeck, Germany, and established in 1889, Drägerwerk AG & Co. KGaA is a global provider of advanced medical and safety technology solutions. The company serves a diverse international clientele across Europe, the Americas, Africa, Asia, and Australia. Within the medical field, Drägerwerk develops and markets comprehensive system solutions, equipment, and support services tailored for acute care environments. This encompasses emergency services, surgical procedures (perioperative care), intensive care units (critical care), and specialized newborn care (perinatal care). Their extensive product portfolio includes items such as anesthesia machines, respiratory ventilators, temperature management devices, monitoring systems for patients, and associated software and consumables. For safety applications, the company delivers essential products, integrated systems, and services designed for personal protection, sophisticated gas detection, and holistic hazard management. These offerings cater to industrial and mining operations, as well as public safety organizations like fire brigades, police forces, and disaster relief agencies. Key safety products range from fixed and portable gas sensing equipment to personal protective gear and devices for alcohol and drug screening. Furthermore, Drägerwerk extends its expertise through various training programs, comprehensive service packages, and even dedicated fire training facilities for emergency responders.
Technical Analysis
Carl Zeiss Meditec
―
Eckert & Ziegler Strahlen und Medizintechnik
―
MeVis Medical Solutions
―
STRATEC Biomedical
―
Siemens Healthineers AG
―